Neoadjuvant paclitaxel (P), carboplatin (Ca) and gemcitabine (G) in patients with locally advanced transitional cell carcinoma (TCC) of the bladder: A final report.

被引：0
|
作者：
Smith, D. C.
Mackler, N. J.
Hussain, M. H.
Dunn, R.
Montie, J. E.
Wood, D.
Lee, C. T.
Petrylak, D.
Quinn, D.
Vaishampayan, U.
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Columbia Presbyterian Med Ctr, New York, NY USA
[3] Univ So Calif, Los Angeles, CA USA
[4] Wayne State Univ, Detroit, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：226S / 226S
页数：1
相关论文
共 50 条
  • [21] Toripalimab Plus Paclitaxel and Carboplatin as Neoadjuvant Therapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
    He, Wenwu
    Leng, Xuefeng
    Mao, Tianqin
    Luo, Xi
    Zhou, Lingxiao
    Yan, Jiaxin
    Peng, Lin
    Fang, Qiang
    Liu, Guangyuan
    Wei, Xing
    Wang, Kangning
    Wang, Chenghao
    Zhang, Sha
    Zhang, Xudong
    Shen, Xudong
    Huang, Depei
    Yi, Huan
    Bei, Ting
    She, Xueke
    Xiao, Wenguang
    Han, Yongtao
    ONCOLOGIST, 2022, 27 (01): : E18 - E28
  • [22] Chemotherapy with gemcitabine, paclitaxel, and cisplatin in the treatment of patients with advanced transitional cell carcinoma of the urothelium
    Ecke, Thorsten H.
    Bartel, Peter
    Koch, Stefan
    Ruttloff, Juergen
    Theissig, Franz
    ONCOLOGY REPORTS, 2006, 16 (06) : 1381 - 1388
  • [23] NEOADJUVANT METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN FOR LOCALLY ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE BLADDER
    MILLER, RJ
    BAHNSON, RR
    BANNER, B
    ERNSTOFF, MS
    ODONNELL, WF
    CANCER, 1990, 65 (02) : 207 - 210
  • [24] Gemcitabine (GEM) and cisplatin (Cis) in advanced/metastatic transitional cell carcinoma (TCC) of bladder:: Phase II study.
    Adamo, V
    D'Angelo, A
    Ferraro, G
    Alafaci, E
    Altavilla, G
    Garipoli, C
    Magno, C
    Scimone, A
    Zanghì, M
    ANNALS OF ONCOLOGY, 2000, 11 : 79 - 79
  • [25] Phase II multicenter trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) for patients (pts) with transitional cell carcinoma (TCC) of the bladder
    Barriuso, J.
    Daugaard, G.
    Frentzas, S.
    Fuglsang, L.
    Glasspool, R.
    Krarup-Hansen, A.
    Jones, R. J.
    Lassen, U.
    Sengelov, L.
    De Bono, J. S.
    EJC SUPPLEMENTS, 2008, 6 (12): : 67 - 68
  • [26] Gemcitabine and carboplatin chemotherapy in advanced transitional cell carcinoma in regard to patients with impaired renal function
    Helke, C.
    May, M.
    Hoschke, B.
    AKTUELLE UROLOGIE, 2006, 37 (05) : 363 - 368
  • [27] Safety and efficacy of neoadjuvant chemotherapy with paclitaxel, carboplatin, and cetuximab for locally advanced head and neck squamous cell carcinoma
    Tanaka, Ryoko
    Ueki, Yushi
    Ohshima, Shusuke
    Omata, Jo
    Yokoyama, Yusuke
    Takahashi, Takeshi
    Shodo, Ryusuke
    Yamazaki, Keisuke
    Ohtaki, Kohei
    Togashi, Takafumi
    Horii, Arata
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (08) : 1133 - 1141
  • [28] PHASE II STUDY OF CARBOPLATIN IN LOCALLY ADVANCED AND METASTATIC TRANSITIONAL CELL-CARCINOMA OF THE URINARY-BLADDER
    RAABE, NK
    FOSSA, SD
    PARO, G
    BRITISH JOURNAL OF UROLOGY, 1989, 64 (06): : 604 - 607
  • [29] Paclitaxel, carboplatin, and gemcitabine in the treatment of patients with advanced transitional cell carcinoma of the urothelium - A phase II trial of the Minnie Pearl Cancer Research Network
    Hainsworth, JD
    Meluch, AA
    Litchy, S
    Schnell, FM
    Bearden, JD
    Yost, K
    Greco, FA
    CANCER, 2005, 103 (11) : 2298 - 2303
  • [30] Phase II trial of neoadjuvant cisplatin, gemcitabine, and bevacizumab followed by radical cystectomy (RC) in patients with muscle-invasive transitional cell carcinoma (TCC) of the bladder
    Chaudhary, U. B.
    Golshayan, A. R.
    Brisendine, A.
    Kraft, A. S.
    Clarke, H.
    Keane, T. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
12345